Evernorth Holdings Inc. has entered the public market through its completed business combination with Armada Acquisition Corp. II, bringing its XRP-focused digital asset treasury...
The U.S. IPO market continued to lose momentum in the week ended October 9, 2026, as newly listed biotechnology companies delivered mixed results and...
Key Points
US IPO activity remained selective as Retension Pharmaceuticals and TRex Bio completed offerings, while Pine Tree Acquisition added a special-purpose acquisition company...
Key Points:
XFUNDS has launched the XFUNDS Technology Income ETF (VGTX), an actively managed fund combining US technology equities with options strategies designed to...
Retension Pharmaceuticals, Inc. has priced its upsized initial public offering at $12 per share, raising approximately $45 million in gross proceeds to advance its...